MyChoice is a Toronto-based insurtech helping brokers and carriers improve submission quality and underwriting confidence. MyChoice improves operational efficiency, accelerates binding, and helps ...
Myriad Genetics, Inc. MYGN recently submitted a supplementary premarket approval (sPMA) application to the FDA for its myChoice CDx test. This will enable the identification of women suffering from ...
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...
The filing comes as recent upgrades to NCCN guidelines expand the role of testing in the treatment of ovarian cancer. Myriad Genetics this week submitted the first part of its application to the FDA ...
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that the U.S. Food and Drug Administration ...
WEST DES MOINES, Iowa, Sept. 23, 2020 /PRNewswire/ -- A series of special reports released this month by Businessolver®, a leader in SaaS-based benefits technology and services, expose how COVID-19 ...
A new Ontario driving study from MyChoice ranked Toronto as the safest city to drive in the province, based on a weighted ...
The University of Chicago’s myCHOICE (Chicago Options in Career Empowerment) program, which launched in 2014 to broaden experiences in scientific training and career exploration for PhD students, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results